Pandect Bioventures

Pandect Bioventures is an active venture capital firm founded in 2018 in South San Francisco. It provides seed to Series A and later funding to early-stage biotech and pharma startups with full management support. The firm leverages a large incubator facility and exclusive relationships with research institutions to identify transformational healthcare ideas at the earliest stage. Its investment focus includes oncology, rare diseases, regenerative medicine, autoimmune diseases, and advanced therapeutic modalities such as cell-based therapies and macrocyclic peptides. Key investments include Circle Pharma (macrocyclic peptide therapeutics for cancer), Azkarra Therapeutics (oncology/DNA damage response), Walking Fish Therapeutics (B cell medicines), among others.